SDGR (SDGR) revenue breakdown
By segment, Software is the largest at 78% of fiscal 2025 revenue; Drug discovery grew fastest, 20% a year over 6 years.
By product, Software products and services is the largest at 78% of fiscal 2025 revenue; Drug discovery grew fastest, 20% a year over 6 years.
Revenue by segment
Fiscal years, as SDGR reports them in its 10-K filings; fiscal 2025 total $256M.
| Segments | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|
| Software | $67M | $93M | $113M | $136M | $159M | $180M | $200M | 78% |
| Drug discovery | $19M | $16M | $25M | $45M | $58M | $27M | $56M | 22% |
Revenue by product
Fiscal years, as SDGR reports them in its 10-K filings; fiscal 2025 total $256M.
| Products | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|
| Software products and services | $67M | $93M | $113M | $136M | $159M | $180M | $200M | 78% |
| Drug discovery | $19M | $16M | $25M | $45M | $58M | $27M | $56M | 22% |
Revenue by region
Fiscal years, as SDGR reports them in its 10-K filings; fiscal 2025 total $256M.
| Regions | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|
| United States | $48M | $61M | $90M | $124M | $162M | $115M | $153M | 60% |
| EMEA | — | — | $29M | $34M | $29M | $66M | $75M | 29% |
| APAC | — | — | $18M | $22M | $25M | $26M | $26M | 10% |
| Rest of World | $6M | $8M | $875,000 | $1M | $1M | $1M | $2M | 1% |
| Europe | $18M | $24M | — | — | — | — | — | — |
| Japan | $14M | $15M | — | — | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for SDGR.
Open SDGR in InvestinglyQuestions
Where does SDGR make its money?
In fiscal 2025, by segment: Software $200M, Drug discovery $56M.
From SDGR's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.